GI Oncology
Conference Coverage
Altering gut microbiome may reduce tumor-promoting effects of smoking
Mice treated with microbiome-depleting antibiotics or genetically modified to lack an adaptive immune response did not show increased rates of...
Perspectives
Multigene panel testing for colorectal cancer
This is the debut column of Perspectives, which features pro/con expert debates.
From the Journals
Certain anaerobic bacteria linked to increased CRC risk
Anaerobic bacteria have been linked to an increased risk of colorectal cancer, but it isn’t clear if the bacteria are causing the cancers.
News from the FDA/CDC
FDA approves first targeted drug for bile duct cancer
From the Journals
Genotyping improves accuracy of pancreatic cancer tumor markers
Stratifying tumor marker cut-off levels based on genetic variants may improve detection of pancreatic cancer.
From the Journals
Liver cancer risk reduced by aspirin in chronic viral hepatitis
Patients taking low-dose aspirin had a 31% lower risk of hepatocellular carcinoma.
News from the FDA/CDC
Age divide seen in colorectal cancer screening use
Americans aged 65-75 years are significantly more likely than 50- to 64-year-olds to be up to date with colorectal cancer screening.
From the Journals
Study eyes gastric cancer predictors in Lynch syndrome
Risk factors included older age, male sex, family history, and having pathogenic variants in MLH1 or MSH2.
From the Journals
Bariatric surgery may curtail colorectal cancer risk
From the Journals
Molecularly guided therapy in pancreatic cancer: Untapped potential and the ‘bright future’ ahead
Molecularly guided therapy improved overall survival in a retrospective study, but this treatment approach was underused.